AAPL   381.91 (-0.46%)
MSFT   214.40 (+0.34%)
FB   247.00 (+0.79%)
GOOGL   1,549.94 (+0.71%)
NVDA   402.09 (-4.07%)
CGC   17.35 (-0.40%)
MU   50.70 (+0.00%)
GE   6.72 (+0.30%)
AMD   56.72 (+1.50%)
T   29.77 (-1.20%)
F   6.07 (-0.49%)
GILD   76.68 (+0.47%)
DIS   116.25 (-2.59%)
NFLX   525.50 (-4.23%)
BAC   24.18 (+0.67%)
BA   180.39 (+1.09%)
AAPL   381.91 (-0.46%)
MSFT   214.40 (+0.34%)
FB   247.00 (+0.79%)
GOOGL   1,549.94 (+0.71%)
NVDA   402.09 (-4.07%)
CGC   17.35 (-0.40%)
MU   50.70 (+0.00%)
GE   6.72 (+0.30%)
AMD   56.72 (+1.50%)
T   29.77 (-1.20%)
F   6.07 (-0.49%)
GILD   76.68 (+0.47%)
DIS   116.25 (-2.59%)
NFLX   525.50 (-4.23%)
BAC   24.18 (+0.67%)
BA   180.39 (+1.09%)
AAPL   381.91 (-0.46%)
MSFT   214.40 (+0.34%)
FB   247.00 (+0.79%)
GOOGL   1,549.94 (+0.71%)
NVDA   402.09 (-4.07%)
CGC   17.35 (-0.40%)
MU   50.70 (+0.00%)
GE   6.72 (+0.30%)
AMD   56.72 (+1.50%)
T   29.77 (-1.20%)
F   6.07 (-0.49%)
GILD   76.68 (+0.47%)
DIS   116.25 (-2.59%)
NFLX   525.50 (-4.23%)
BAC   24.18 (+0.67%)
BA   180.39 (+1.09%)
AAPL   381.91 (-0.46%)
MSFT   214.40 (+0.34%)
FB   247.00 (+0.79%)
GOOGL   1,549.94 (+0.71%)
NVDA   402.09 (-4.07%)
CGC   17.35 (-0.40%)
MU   50.70 (+0.00%)
GE   6.72 (+0.30%)
AMD   56.72 (+1.50%)
T   29.77 (-1.20%)
F   6.07 (-0.49%)
GILD   76.68 (+0.47%)
DIS   116.25 (-2.59%)
NFLX   525.50 (-4.23%)
BAC   24.18 (+0.67%)
BA   180.39 (+1.09%)
Log in

NYSE:CVSCVS Health Stock Price, Forecast & News

$62.63
-0.02 (-0.03 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$62.37
Now: $62.63
$63.54
50-Day Range
$61.28
MA: $64.97
$70.62
52-Week Range
$52.04
Now: $62.63
$77.03
Volume5.50 million shs
Average Volume7.51 million shs
Market Capitalization$81.86 billion
P/E Ratio11.35
Dividend Yield3.19%
Beta0.76
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. The company's Retail/LTC segment sells prescription drugs and general merchandise, such as over-the-counter drugs, beauty products, cosmetics, and personal care products, as well as provides health care services through its MinuteClinic walk-in medical clinics. Its Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management, Medicare plans, PDPs, Medicaid health care management services, workers' compensation administrative services, and health information technology products and services. The company's customers include employers, insurance companies, unions, government employee groups, health plans, Medicare Part D prescription drug plans, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans, individuals, college students, workers, labor groups, and expatriates. As of December 31, 2018, it had approximately 40 leased on-site pharmacies, 25 leased retail specialty pharmacy stores, 20 specialty mail order pharmacies, and 90 branches for infusion and enteral services; and 9,900 retail locations and 1,100 MinuteClinic locations, as well as operated an online retail pharmacy Websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Read More
CVS Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.5Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.61 out of 5 stars


Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
CUSIP12665010
Phone401-765-1500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$256.78 billion
Cash Flow$10.46 per share
Book Value$49.33 per share

Profitability

Net Income$6.63 billion

Miscellaneous

Employees290,000
Outstanding Shares1,307,090,000
Market Cap$81.86 billion
Next Earnings Date8/5/2020 (Confirmed)
OptionableOptionable

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

CVS Health (NYSE:CVS) Frequently Asked Questions

How has CVS Health's stock been impacted by COVID-19 (Coronavirus)?

CVS Health's stock was trading at $61.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CVS shares have increased by 2.2% and is now trading at $62.63. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of CVS Health?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings, 14 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CVS Health.

When is CVS Health's next earnings date?

CVS Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for CVS Health.

How can I listen to CVS Health's earnings call?

CVS Health will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) released its quarterly earnings data on Wednesday, May, 6th. The pharmacy operator reported $1.91 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.63 by $0.28. The pharmacy operator had revenue of $66.76 billion for the quarter, compared to the consensus estimate of $64.11 billion. CVS Health had a net margin of 2.76% and a return on equity of 15.17%. The firm's revenue for the quarter was up 8.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.62 EPS. View CVS Health's earnings history.

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health declared a quarterly dividend on Wednesday, July 8th. Investors of record on Thursday, July 23rd will be paid a dividend of $0.50 per share on Monday, August 3rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.19%. The ex-dividend date of this dividend is Wednesday, July 22nd. View CVS Health's dividend history.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health updated its FY 2020 After-Hours earnings guidance on Wednesday, June, 10th. The company provided earnings per share guidance of 7.04-7.17 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.13.

What price target have analysts set for CVS?

19 brokerages have issued 1 year price targets for CVS Health's stock. Their forecasts range from $63.00 to $109.00. On average, they expect CVS Health's share price to reach $80.35 in the next twelve months. This suggests a possible upside of 28.3% from the stock's current price. View analysts' price targets for CVS Health.

Has CVS Health been receiving favorable news coverage?

Media coverage about CVS stock has been trending very negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. CVS Health earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave news stories about the pharmacy operator a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about CVS Health.

Who are some of CVS Health's key competitors?

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), Cisco Systems (CSCO), NVIDIA (NVDA), Alibaba Group (BABA), Johnson & Johnson (JNJ), Verizon Communications (VZ), Home Depot (HD), Bank of America (BAC) and AbbVie (ABBV).

Who are CVS Health's key executives?

CVS Health's management team includes the following people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 63)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 52)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 63)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 55)
  • Mr. Derica W. Rice, Exec. VP & Pres of CVS Caremark (Age 54)

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

Who are CVS Health's major shareholders?

CVS Health's stock is owned by many different institutional and retail investors. Top institutional investors include Envestnet Asset Management Inc. (0.09%), Cacti Asset Management LLC (0.04%), Hexavest Inc. (0.03%), Robecosam AG (0.02%), Rockland Trust Co. (0.02%) and Thomasville National Bank (0.02%). Company insiders that own CVS Health stock include Alan Lotvin, C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View institutional ownership trends for CVS Health.

Which major investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Robecosam AG, HNP Capital LLC, IFM Investors Pty Ltd, Cacti Asset Management LLC, Mount Yale Investment Advisors LLC, DNB Asset Management AS, and Municipal Employees Retirement System of Michigan. Company insiders that have sold CVS Health company stock in the last year include Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo, and Troyen A Brennan. View insider buying and selling activity for CVS Health.

Which major investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Canandaigua National Corp, State of Alaska Department of Revenue, Thomasville National Bank, Cox Capital Mgt LLC, Investment Counsel Inc., Forte Capital LLC ADV, and Cardinal Capital Management Inc.. Company insiders that have bought CVS Health stock in the last two years include Alan Lotvin, C David Brown II, David W Dorman, and Edward J Ludwig. View insider buying and selling activity for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $62.63.

How big of a company is CVS Health?

CVS Health has a market capitalization of $81.86 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 290,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.